micro News and Research

RSS

SPS receives $2.2M NHLBI grant to commercialize steerable cardiac mapping, ablation catheter technology

Strategic Polymer Sciences, Inc. (SPS), an innovator in advanced medical devices based on its proprietary electroactive polymer (EAP) technology, today announced it has received a $2.2 million grant from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH). The SPS grant is one of only ten awarded nationwide by the NIH under a Recovery Act Limited Competition called The Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Pilot Program.

23 Jun 2010

World's first invisible-in-the-canal hearing aid launched

Starkey Laboratories, Inc., one of the world's leading hearing technology companies, is excited to introduce the S Series™ iQ OtoLens™, the world's first invisible-in-the-canal (IIC) hearing aid. OtoLens, a custom-molded hearing aid built using Starkey's Comfort Fit process, lives in the second bend of the ear, meaning that it is truly 100 percent invisible.

22 Jun 2010

Simulations Plus third-quarter consolidated preliminary revenues up 14.9% to $3.1M

Simulations Plus, Inc., a leading provider of software for pharmaceutical discovery and development, today released preliminary revenues for its third fiscal quarter ended May 31, 2010.

21 Jun 2010

Antibacterial lab coats to help prevent spread of disease in hospitals

According to the Centers for Disease Control and Prevention, 99,000 people die every year from infections acquired while in hospitals. "The goal in our profession is to help cure you not introduce you to another deadly infection," said Dr. Charles Kinder, Heart Rhythm expert and Director of Heart Rhythm Program at Heart Care Centers of Illinois.

21 Jun 2010

New Brunswick Scientific, Pall partner to develop new disposable bioreactor systems

New Brunswick Scientific, an Eppendorf Company, and Pall Corporation today announced a joint product development and marketing agreement to create and supply new disposable bioreactor systems.

From Pall Corporation 14 Jun 2010

'Micro-ear' to screen for malaria, sleeping sickness

A team of researchers from the Universities of Glasgow and Oxford, and the UK's National Institute of Medical Research at Mill Hill, are developing a 'micro-ear' which may help develop medicines and screening for diseases such as malaria and sleeping sickness in Africa. The project is in two parts, explains Professor Jon Cooper, a bio-engineer at University of Glasgow.

14 Jun 2010

USPTO issues patent covering methods for enhancing RNA silencing activity of RNAi agents

Silence Therapeutics plc announces the issuance of United States patent 7,732,593, titled Methods and Compositions For Controlling Efficacy of RNA Silencing, by the United States Patent and Trademark Office. The issued patent, which is based on the seminal research of Phillip D. Zamore, Ph.D., Howard Hughes Medical Institute Investigator, the Gretchen Stone Cook Chair of Biomedical Sciences, and Professor of Biochemistry & Molecular Pharmacology at University of Massachusetts Medical School, generally claims methods of enhancing the RNA silencing activity of RNA interference (RNAi) agents through certain structural modifications.

14 Jun 2010

Scientists manipulate simple bacteria into constructing internal compartments for biofuels, vaccines

Scientists at the University of Kent and University College Cork have manipulated simple bacteria into constructing internal compartments where biofuels and vaccines can be produced.

14 Jun 2010

Study identifies mechanism that interrupts normal p53 gene function leading to tumor development

The p53 gene has been a well-documented player in the prevention of tumors. It is considered the most frequently mutated gene in human tumors with more than half harboring p53 mutations (Bennett et al., 1999). These mutations often can be caused by disruption in normal p53 function.

11 Jun 2010

Microscopic image sensor to speed up detection of tumors

To diagnose cancer reliably, doctors usually conduct a biopsy including tissue ana-lysis - which is a time-consuming process. A microscopic image sensor, fitted in an endoscope, is being developed for in vivo cancer diagnosis, to speed up the detection of tumors.

7 Jun 2010

SCCT names finalists of fourth annual Young Investigator Award

The Society of Cardiovascular Computed Tomography, the leading international professional society dedicated to research, education and clinical excellence in cardiovascular computed tomography, has named the finalists of the fourth annual Young Investigator Award. Sponsored by Toshiba America Medical Systems, Inc. through an unrestricted educational grant, the Young Investigator Award will be awarded to two residents or fellows in either radiology or cardiology for their patient care research in the categories of technical and clinical advancement of cardiovascular CT.

7 Jun 2010

Raydiance, Rofin partner to offer femtosecond laser technology for manufacture of medical devices

Raydiance, Inc., the innovation leader in ultrafast laser technology, announced today that it is teaming up with Rofin, world-leading manufacturer of laser sources and laser-based solutions for industrial materials processing, to introduce femtosecond laser technology to industrial production.

7 Jun 2010

Microplasmin exhibits potential to cure 50% of patients with macular hole

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the World Ophthalmology Congress by Dr. Matthew Benz, MD (The Methodist Hospital, Houston, Texas, U.S.)

7 Jun 2010

Tomorrow's elderly will need to pay for care

As their autonomy fades, tomorrow's elderly will need to create non-traditional support networks or pay for the care they receive.

2 Jun 2010

Obama's National Security Strategy released, includes global health, food security priorities

"The Obama administration on Thursday released a sweeping statement of its national security goals," the Los Angeles Times reports. The 52-page document "calls for the United States to strengthen international institutions, to heed treaties and norms, and to build stronger ties to allies, including to the emerging powers of India, Brazil and China.

29 May 2010

DFG approves establishment of twelve new CRCs

The Deutsche Forschungsgemeinschaft has approved the establishment of twelve new Collaborative Research Centres beginning 1 July 2010. This was decided by the responsible Grants Committee at its spring meeting in Bonn. The new CRCs will initially be funded for four years with a total of 112 million euros (including a 20% programme allowance for indirect project costs).

29 May 2010

Celsis International updates Drug Master Files with FDA

Celsis International, the global leader in rapid microbial detection, announced it has recently updated its Drug Master Files with the U.S. Food & Drug Administration (FDA) to include information on testing both non-sterile and sterile raw materials, in-process solutions and finished goods on the Celsis system.

28 May 2010

SonoSite signs agreement to acquire privately held Visualsonics

SonoSite, Inc., the world leader and specialist in bedside and point-of-care ultrasound, today announced that it has signed an agreement to acquire privately held Visualsonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology. The aggregate transaction value will be approximately $71 million net of cash and debt.

27 May 2010

Tendons in high-stress areas repair themselves less frequently than low-stress tendons: Study

In a discovery that seems counterintuitive, a study appearing in the May 21st Journal of Biological Chemistry has found that tendons in high-stress and strain areas, like the Achilles tendon, actually repair themselves less frequently than low-stress tendons. This study sheds some light on the increased susceptibility of certain tendons to injury during aging.

27 May 2010

Small segment of a protein can control normal expression of genes: Research

In a major cancer-research breakthrough, researchers at the McGill University, Department of Biochemistry have discovered that a small segment of a protein that interacts with RNA can control the normal expression of genes - including those that are active in cancer.

27 May 2010

micro News and Research

SPS receives $2.2M NHLBI grant to commercialize steerable cardiac mapping, ablation catheter technology

World's first invisible-in-the-canal hearing aid launched

Simulations Plus third-quarter consolidated preliminary revenues up 14.9% to $3.1M

Antibacterial lab coats to help prevent spread of disease in hospitals

New Brunswick Scientific, Pall partner to develop new disposable bioreactor systems

'Micro-ear' to screen for malaria, sleeping sickness

USPTO issues patent covering methods for enhancing RNA silencing activity of RNAi agents

Scientists manipulate simple bacteria into constructing internal compartments for biofuels, vaccines

Study identifies mechanism that interrupts normal p53 gene function leading to tumor development

Microscopic image sensor to speed up detection of tumors

SCCT names finalists of fourth annual Young Investigator Award

Raydiance, Rofin partner to offer femtosecond laser technology for manufacture of medical devices

Microplasmin exhibits potential to cure 50% of patients with macular hole

Tomorrow's elderly will need to pay for care

Obama's National Security Strategy released, includes global health, food security priorities

DFG approves establishment of twelve new CRCs

Celsis International updates Drug Master Files with FDA

SonoSite signs agreement to acquire privately held Visualsonics

Tendons in high-stress areas repair themselves less frequently than low-stress tendons: Study

Small segment of a protein can control normal expression of genes: Research

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News